Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.
Rosenstock, J
Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group. [electronic resource] - Diabetes care Nov 1996 - 1194-9 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0149-5992
10.2337/diacare.19.11.1194 doi
Blood Glucose--metabolism
C-Peptide--blood
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Drug Administration Schedule
Female
Glycated Hemoglobin--analysis
Humans
Hypoglycemic Agents--adverse effects
Insulin--blood
Male
Middle Aged
Postprandial Period
Sulfonylurea Compounds--adverse effects
Time Factors
Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group. [electronic resource] - Diabetes care Nov 1996 - 1194-9 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0149-5992
10.2337/diacare.19.11.1194 doi
Blood Glucose--metabolism
C-Peptide--blood
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Drug Administration Schedule
Female
Glycated Hemoglobin--analysis
Humans
Hypoglycemic Agents--adverse effects
Insulin--blood
Male
Middle Aged
Postprandial Period
Sulfonylurea Compounds--adverse effects
Time Factors